CVS Health Files 8-K with Corporate Details
Ticker: CVS · Form: 8-K · Filed: Dec 9, 2024 · CIK: 64803
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
CVS Health filed an 8-K on 12/9/24 with basic corporate info. Nothing major.
AI Summary
CVS Health Corporation filed an 8-K on December 9, 2024, reporting other events and financial statements. The filing details the company's principal executive offices located at One CVS Drive, Woonsocket, Rhode Island, 02895, and its telephone number is 401-765-1500. The company was incorporated in Delaware and its fiscal year ends on December 31st.
Why It Matters
This filing provides essential corporate information and updates for CVS Health, which is crucial for investors and stakeholders to stay informed about the company's structure and reporting.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting corporate information and does not indicate any significant new risks or events.
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-01011 (company) — SEC File Number
- 05-0494040 (company) — IRS Employer Identification No.
- One CVS Drive, Woonsocket, Rhode Island 02895 (address) — Principal executive offices
- 401-765-1500 (phone_number) — Registrant's telephone number
- December 9, 2024 (date) — Date of earliest event reported
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is CVS HEALTH CORPORATION.
In which state was CVS Health Corporation incorporated?
CVS Health Corporation was incorporated in Delaware.
What is the SEC file number for CVS Health Corporation?
The SEC file number for CVS Health Corporation is 001-01011.
What is the address of CVS Health Corporation's principal executive offices?
The address of CVS Health Corporation's principal executive offices is One CVS Drive, Woonsocket, Rhode Island 02895.
What is the telephone number of CVS Health Corporation?
The telephone number of CVS Health Corporation is 401-765-1500.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-12-09 07:08:28
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
Filing Documents
- d816178d8k.htm (8-K) — 24KB
- d816178dex991.htm (EX-99.1) — 17KB
- g816178g1208041231326.jpg (GRAPHIC) — 3KB
- g816178g1208042305127.jpg (GRAPHIC) — 1KB
- 0001193125-24-272865.txt ( ) — 171KB
- cvs-20241209.xsd (EX-101.SCH) — 3KB
- cvs-20241209_lab.xml (EX-101.LAB) — 17KB
- cvs-20241209_pre.xml (EX-101.PRE) — 11KB
- d816178d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . The exhibit to this Current Report on Form 8-K is as follows: INDEX TO EXHIBITS 99.1 Press Release of CVS Health Corporation dated December 9, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: December 9, 2024 By: /s/ Thomas F. Cowhey Thomas F. Cowhey Executive Vice President and Chief Financial Officer